I. Boler

1.2k total citations · 1 hit paper
8 papers, 832 citations indexed

About

I. Boler is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, I. Boler has authored 8 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 1 paper in Molecular Biology and 1 paper in Dermatology. Recurrent topics in I. Boler's work include Cancer survivorship and care (4 papers), Neutropenia and Cancer Infections (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). I. Boler is often cited by papers focused on Cancer survivorship and care (4 papers), Neutropenia and Cancer Infections (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). I. Boler collaborates with scholars based in United States and Netherlands. I. Boler's co-authors include Martine Extermann, Richard R. Reich, Eric T. Lubiner, Gary H. Lyman, Pablo Reyes, R. H. Brown, Lodovico Balducci, Richard M. Levine, Rachel M. Levine and Mihaela Druta and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Critical Reviews in Oncology/Hematology.

In The Last Decade

I. Boler

8 papers receiving 816 citations

Hit Papers

Predicting the risk of chemotherapy toxicity in older pat... 2011 2026 2016 2021 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Boler United States 5 463 388 257 219 145 8 832
Eric T. Lubiner United States 5 457 1.0× 422 1.1× 246 1.0× 244 1.1× 143 1.0× 9 858
Véronique Girre France 13 445 1.0× 556 1.4× 260 1.0× 291 1.3× 172 1.2× 21 1.1k
S. Klapper United States 5 708 1.5× 561 1.4× 387 1.5× 327 1.5× 240 1.7× 7 1.3k
Laurent Cany France 15 350 0.8× 709 1.8× 332 1.3× 336 1.5× 84 0.6× 38 1.2k
Antonella Venturino Italy 14 249 0.5× 533 1.4× 139 0.5× 279 1.3× 91 0.6× 57 953
Chie Akiba United States 5 333 0.7× 223 0.6× 195 0.8× 131 0.6× 107 0.7× 7 597
J.M. Jonker Netherlands 6 334 0.7× 187 0.5× 236 0.9× 121 0.6× 98 0.7× 6 609
Jérôme Dauba France 14 363 0.8× 738 1.9× 355 1.4× 497 2.3× 82 0.6× 54 1.3k
Marika Rasschaert Belgium 12 209 0.5× 261 0.7× 153 0.6× 109 0.5× 72 0.5× 32 545
François Chomy France 11 217 0.5× 304 0.8× 239 0.9× 251 1.1× 54 0.4× 29 727

Countries citing papers authored by I. Boler

Since Specialization
Citations

This map shows the geographic impact of I. Boler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Boler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Boler more than expected).

Fields of papers citing papers by I. Boler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Boler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Boler. The network helps show where I. Boler may publish in the future.

Co-authorship network of co-authors of I. Boler

This figure shows the co-authorship network connecting the top 25 collaborators of I. Boler. A scholar is included among the top collaborators of I. Boler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Boler. I. Boler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Liu, Jane Jijun, Mihaela Druta, David Shibata, et al.. (2013). Metabolic syndrome and colorectal cancer: Is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?. Journal of Geriatric Oncology. 5(1). 40–48. 25 indexed citations
2.
Extermann, Martine, I. Boler, Richard R. Reich, et al.. (2011). Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score. Cancer. 118(13). 3377–3386. 758 indexed citations breakdown →
3.
Janssen‐Heijnen, M.L.G., Martine Extermann, & I. Boler. (2010). Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy?. Critical Reviews in Oncology/Hematology. 79(1). 43–50. 10 indexed citations
4.
Extermann, Martine, I. Boler, Richard R. Reich, et al.. (2010). The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: Design and validation.. Journal of Clinical Oncology. 28(15_suppl). 9000–9000. 29 indexed citations
5.
Extermann, Martine, I. Boler, R. H. Brown, et al.. (2009). P106 Comparison of older patients receiving chemotherapy in the community versus an academic cancer center. Critical Reviews in Oncology/Hematology. 72(1). S56–S56. 1 indexed citations
6.
Boler, I., Andrew Davis, Martine Extermann, & Janine Overcash. (2007). P.4 Muscle weakness, dehydration, and confusion, but not anemia and fatigue, are associated with falls in older cancer patients receiving chemotherapy. Critical Reviews in Oncology/Hematology. 64. S36–S36. 1 indexed citations
7.
Extermann, Martine, I. Boler, John D. Blair, et al.. (2006). 9 Prevalence of multiple cancers in Floridian patients aged 70 years and older. Critical Reviews in Oncology/Hematology. 60. S27–S27. 4 indexed citations
8.
Extermann, Martine, I. Boler, Eoghan O’Neill, et al.. (2006). Muscle weakness is a significant problem in older patients receiving chemotherapy. Journal of Clinical Oncology. 24(18_suppl). 8545–8545. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026